May 7, 2020 / 9:30 PM / 24 days ago

BRIEF-Arena Pharmaceuticals Q1 Loss Per Share $2.00

May 7 (Reuters) - Arena Pharmaceuticals Inc:

* ARENA ANNOUNCES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 REVENUE ESTIMATE $1.6 MILLION — REFINITIV IBES DATA

* Q1 EARNINGS PER SHARE ESTIMATE $-2.28 — REFINITIV IBES DATA

* CASH USED IN OPERATING ACTIVITIES FOR FULL-YEAR 2020 IS EXPECTED TO BE $400 MILLION TO $430 MILLION

* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE $1.0 BILLION AT MARCH 31, 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below